Open-Label Study of ARD-0403 in Testosterone Deficient Men
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
Male hypogonadism, a disorder associated with testosterone deficiency, is frequently seen in
clinical practice and has significant effects on patient wellbeing. The purpose of this study
is to investigate the efficacy and safety of ARD-0403 as a testosterone replacement therapy
in testosterone deficient men.